Hundreds of cases have been diagnosed, now the FDA wants physicians to be on the lookout.
Officials from the U.S. Food and Drug Administration (FDA) are warning that they are seeing more cases of a rare cancer linked to breast implants and they want doctors to be on the lookout for warning signs.
The cancer is a type of lymphoma called breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
The FDA reports that at least 457 people have developed the disease and nine have died since the ailment was first reported in 2011.
This lymphoma is a type of non-Hodgkin’s lymphoma, which means it’s a cancer that affects immune system cells.
The disease can occur in multiple parts of the body, including the lymph nodes and skin. While it can occur in breast tissue, it isn’t breast cancer.